InnoCare Pharma Goes Back to Funding Trough With STAR Market Listing
The Hong Kong-traded company will become the latest from the cash-challenged pharma sector to make a second listing on the A-share market Key Takeaways: InnoCare Pharma’s A-share IPO will make…
RELATED ARTICLES
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK -
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
- Uni-Star under fire as its hit games enter twilight phase
-
Cash-hungry Mabwell seeks financial tonic from Hong Kong investors
688062.SHG
- Innogen Pharma jostles for a slice of the weight-loss market
- Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
- Cancer drug maker Genfleet joins Hong Kong IPO influx
